Background: The need for immunosuppression in autoimmune hepatitis is established.
Previous studies have investigated short‐term outcomes in patients who respond to …

Autoimmune hepatitis (AIH) is a necro-inflammatory disease that, untreated, carries a 3-year
mortality rate of approximately 50%. In this last of a series of three articles, current …

Autoimmune hepatitis (AIH) was the first chronic liver disease which responded favorably to
drug therapy. It has a dismal prognosis when not treated. Since the original description in …

Abstract Background & Aims We sought to identify predictors of outcome for people living
with autoimmune hepatitis (AIH). Methods We evaluated the clinical course of people with …

To identify prognostic features and to define the role of liver transplantation in severe
autoimmune chronic active hepatitis, findings before and after corticosteroid therapy in 111 …

Background & Aims The long-term outcomes of patients treated for autoimmune hepatitis
(AIH) are considered to be good. However, follow-up data beyond 10 years are limited and …

Autoimmune hepatitis (AIH) is a chronic liver disease that can result in hepatic fibrosis and
progress to cirrhosis and need for liver transplantation. Corticosteroids and azathioprine …

Introduction and aim Autoimmune hepatitis (AIH) may present acutely, which can rapidly
progress to fulminant type. This pattern has been described worldwide but is generally …

Background and Aims A 40% risk of disease recurrence post-liver transplantation (LT) for
autoimmune hepatitis (AIH) has been previously reported. Risk factors for recurrence and its …

First described in 1950, autoimmune hepatitis (AIH) was the first chronic liver disease with a
favorable response to drug therapy and a dismal prognosis when left untreated. In the …